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Tumor suppressora b s t r a c t
H-REV107-like family proteins TIG3 and H-REV107 are class II tumor suppressors. Here we report
that the C-terminal domains (CTDs) of TIG3 and H-REV107 can induce HeLa cell death indepen-
dently. The N-terminal domain (NTD) of TIG3 enhances the cell death inducing ability of CTD, while
NTD of H-REV107 plays an inhibitory role. The solution structure of TIG3 NTD is very similar to that
of H-REV107 in overall fold. However, the CTD binding regions on NTD are different between TIG3
and H-REV107, which may explain their functional difference. As a result, the ﬂexible main loop
of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
H-REV107-like family is one divergence of the NlpC/P60 super-
family in eukaryotes [1]. Members of the H-REV107-like family
include H-REV107, TIG3, A-C1, HRASLS2 and iNAT, and they func-
tion as class II tumor suppressors and involve in the regulation of
cell proliferation [2–9]. TIG3 (also known as RIG1, HRASLS4 or
RARRES3) and H-REV107 (also known as HRASLS3, H-REV107-1,
AdPLA) are ubiquitously expressed in many normal tissues, but
their expression levels are decreased in most cancer tissues
[10–12]. They share a high sequence identity of 49% (Fig. 1A),
and both contain a conserved N-terminal NlpC/P60 domain with
phospholipase A1/2 activity, along with a hydrophobic C-terminal
transmembrane domain [13–19].
Overexpression of either TIG3 or H-REV107 can inhibit pro-
liferation and induce apoptosis in tumor cell lines [3,11,20–23]. Itwas proposed that the pro-apoptotic activity of TIG3 and
H-REV107 is dependent on the NC motifs (residues 111–123)
located on the N-terminal domain, and NC-motifs of both proteins
can induce cell death independently [24,25]. Meanwhile, it was
reported that C-terminal domain truncation abolishes the cell
death inducing ability for TIG3 and H-REV107 [3,20,21,26], and
the C-terminal domain (residues 124–164) alone of TIG3 was also
found to induce apoptosis in keratinocytes [27]. Roles of N- and C-
terminal domains of TIG3 and H-REV107 in tumor suppression
remain to be elucidated.
Both C-terminal domains are required for the subcellular local-
ization, as C-terminal 25 or 37 residues truncated forms of TIG3
and H-REV107 are evenly diffused in SCC-13, HeLa or COS-7 cells
[13,14,20,28]. TIG3 was found to localize at ER and Golgi in HtTA
cells, and at centrosome in SCC-13 cells [21,28,29], while H-
REV107 was reported to partially localize in peroxisomes in HeLa
and HEK293 cells [30]. However, the C-terminal residues 134–
164 of TIG3 was found to localize at mitochondria in SCC-13 cells,
and it was proposed that residues 102–125 are responsible for the
centrosome targeting [28]. Therefore, the N-terminal domain of
TIG3 also plays an important role in its subcellular localization,
and it is not clear whether the N-terminal domain of H-REV107
has a similar role.
Fig. 1. Sequences alignment and expression constructs of TIG3 and H-REV107. (A) Sequences alignment of TIG3 and H-REV107 (generated using ClustalW2 [44] and
ESPript3.0 [45]). Secondary structural elements for residues 1–125 are based on the solution structures, and the transmembrane helices (blue box) are predicted using
PHDhtm [46,47]. The main loops are indicated with dashed lines, and residues consisted of CTD binding regions are indicated with blue stars. Every 10th residue is indicated
with a dot above the sequences. (B) Schematic representation of different TIG3 and H-REV107 constructs expressed in HeLa cells and E. coli.
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2KYT) of the N-terminal domain of H-REV107 (H-REV107N, resi-
dues 1–125) [19], which reveals that H-REV107N adopts a fold
highly similar to those of the NlpC/P60 peptidase domains with a
conserved Cys-His-His catalytic triad [17,18]. Here we report the
solution NMR structure of the N-terminal domain (NTD) of TIG3
(TIG3N, residues 1–125). We also found that C-terminal domains
(CTDs) of TIG3 and H-REV107 can independently induce HeLa cell
death at a comparable level, while their NTDs play opposite roles in
regulating the cell death activity of CTDs, even though the overall
folds of TIG3N and H-REV107N are highly similar. Such functional
difference is probably due to different NTD/CTD interaction
patterns between TIG3 and H-REV107.
2. Materials and methods
2.1. Expression vector construction
TIG3 and H-REV107, as well as their domains, mutants, and
hybrid proteins (Fig. 1B), were expressed in HeLa cells as blue ﬂuo-
rescent protein (BFP) fusion proteins. DNA fragment encoding BFP
was subcloned in-frame into Not I and Cla I sites of pcDNA3.1
vector, and DNA fragments encoding the desired proteins were
inserted into BspE I and Xba I sites downstream. Between BFP
and the desired proteins, there is a linker consisted of ten amino
acids (GGGGSGGGGS). For the protein expression in Escherichia
coli, DNA fragments encoding the different segments indicated in
Fig. 1B from TIG3 and H-REV107 were subcloned into pET21a or
pET24a vectors (Novagen, Germany) between Nde I and Xho I sites,
respectively.2.2. Cell culture, transfection and subcellular localization
determination
HeLa cells were maintained in DMEM culture medium
(Solarbio, China) containing 10% FBS (Gibco, USA), incubated at
37 C in 5% CO2. Cells were seeded in 24-well plates for plasmids
transfection. Transfection of cells was performed using
X-tremeGENE HP DNA Transfection Reagent (Roche, USA).
Plasmids (500 ng/well) and transfection reagent were diluted in
Opti-MEMmedium (Gibco, USA), and mixed at room temperature
for 30 min. The mixture was added to cells and incubated for 6 h,
then the cells were refreshed with complete medium.
Mitochondria were labeled with MitoTracker Red CMXRos (Life
Technologies, USA). Peroxisomes were labeled with CellLight
Peroxisome-GFP, BacMam 2.0 (Life Technologies, USA). Images
were taken with ﬂuorescence microscope (Leica DMI 6000B).2.3. Cell death assay
The transfected cells were harvested at 24 h and 48 h post-
transfection with trypsin–EDTA (Solarbio, China) and rinsed twice
with PBS, then stained using 1 lg/mL propidium iodide (PI) for
15 min. The samples were sorted with a MoFlo cell sorter (Dako
Cytomation, USA) and the data were analyzed using Summit
Software (version 4.0, Dako Cytomation, USA). The cell death rate
was the percentage of dead cells out of all the cells which
expressed the target proteins, namely the amount ratio of cells
with both red (PI) and blue (BFP) ﬂuorescence to cells with blue
ﬂuorescence.
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The protein expression and puriﬁcation were performed as
described previously [31,32]. The NMR samples contained
0.5 mM isotopic labeled protein in 50 mM PBS (pH 7.0), with
50 mM NaCl, 20 mM DTT, 0.03% DSS, and 10% D2O. NMR spectra
were acquired on Bruker Avance 500 MHz, 600 MHz, 700 MHz, or
800 MHz spectrometers (Bruker, Germany) with cryoprobes, and
NMR experiments were conducted using TopSpin 2.0.
The backbone resonance assignments were obtained based on
2D 1H-15N HSQC, 3D HNCACB, CBCA(CO)NH, HNCA, and
HBHA(CO)NH experimental data. The side-chain resonance assign-
ments were obtained based on 3D (H)CCH-COSY, (H)CCH-TOCSY
and HCCH-COSY experimental data. 3D 15N-edited NOESY-HSQC
and 13C-edited NOESY-HSQC spectra were collected with the mix-
ing time of 100 ms, and were used for assignment conﬁrmation
and structure calculation. 15N and 13C chemical shifts were refer-
enced indirectly to DSS [33]. All NMR spectra were processed using
NMRPipe [34] and analyzed with NMRView [35].
2.5. Structure calculation
Distance restraints were derived from NOESY spectra and dihe-
dral angel (u, w) restraints from analysis of chemical shifts using
TALOS [36]. Initial structures were generated using CYANA
[37,38], which were used as ﬁlter models for automated NOE
assignments with SANE [39]. The new distance restraints were
then used for the next round of structure calculation with
DYANA [37], together with dihedral angel restraints and hydrogen
bond restraints. For the ﬁnal round, 200 structures were calculated,
and 100 structures with the lowest target function were selected as
the initial structures for reﬁnement. Structure reﬁnement was car-
ried out using the generalized Born (GB) solvent model in AMBER
[40]. Finally, twenty structures with the lowest AMBER energies
were selected for representation. The quality of ﬁnal structures
was analyzed using SUPPOSE [41] and PROCHECK_NMR [42,43].
The mean structure was generated using SUPPOSE and was energy
minimized in AMBER.
The solution structure has been deposited in PDB: 2MY9, and
the chemical shift assignments have been deposited in BMRB:
25448.
3. Results
3.1. Cell death inducing activity of TIG3 and H-REV107
We constructed eukaryotic expression plasmids encoding the
full-length proteins of TIG3 and H-REV107, as well as their NTDs
(BFP-TIG3N and BFP-H-REV107N, residues 1–125) and CTDs
(BFP-TIG3C, residues 126–164; BFP-H-REV107C, residues
126–162), with BFP tag fused to the N terminus (Fig. 1B). The plas-
mids were transfected into HeLa cells for the comparison of the
ability in promoting cell death.
In consistent with previous reports, both H-REV107N and
TIG3N had no effect on the cell viability (Fig. 2A), indicating that
neither NTD alone is capable of inducing HeLa cell death.
However, expression of either TIG3C or H-REV107C can induce
HeLa cell death at comparable death rates. At 24 h and 48 h post-
transfection, TIG3C led to 18% and 42% cell death rates, and those
were 18% and 33% for H-REV107C, respectively (Fig. 2A).
Interestingly, full-length TIG3 resulted in higher cell death rates
of 37% and 71% at 24 h and 48 h, while those for full-length
H-REV107 were much lower, which are 11% and 21% (Fig. 2A).
These indicate that CTDs for both TIG3 and H-REV107 are the pre-
dominant death domains, which can induce cell deathindependently in HeLa cells. Meanwhile, their NTDs play different
roles in modulating the cell death inducing ability of their CTDs,
with TIG3N acting as an enhancer while H-REV107N as a repressor.
This functional difference of NTDs leads to dramatic higher cell
death rates for TIG3, compared to H-REV107, despite their CTDs
induce cell death at a similar level.
As C-terminal domains of TIG3 and HREV107 are reported to be
required for their subcellular localization [13,14,20,28], we com-
pared the subcellular localization of their NTDs and CTDs. It is
apparent that both TIG3N and H-REV107N were diffused in the
cytoplasm, while both H-REV107C and TIG3C showed punctate
distribution in HeLa cells. TIG3C was colocalized with mitochon-
dria (stained with MitoTracker Red CMXRos) (Fig. 2B), consistent
with previous study results in SCC-13 cells [28]. H-REV107C was
colocalized with peroxisomes (indicated with CellLight
Peroxisome-GFP) (Fig. 2B), the same as previously reported for full
length H-REV107 in HeLa cells [30].
In order to determine whether the abilities of TIG3 and H-
REV107 NTDs in modulating cell death are independent of their
CTDs, we constructed plasmids encoding hybrid proteins to swap
the NTDs and CTDs of TIG3 and H-REV107, by fusing H-REV107N
to TIG3C (designated as HNTC) or fusing TIG3N to H-REV107C
(designated as TNHC) (Fig. 1B), and the plasmids were transfected
into HeLa cells. HNTC showed similar punctate distribution as
TIG3C as well as the colocalization with mitochondria (Fig. 2B). It
induced 19% and 37% cell death at 24 h and 48 h post-transfection,
which were also similar to those of TIG3C (Fig. 2A), indicating that
H-REV107N does not affect the function of TIG3C. However, TNHC
turned out to be diffused in the cytoplasm (Fig. 2B) without induc-
ing cell death (Fig. 2A), which suggests that TIG3N abolishes the
targeting and cell death inducing functions of H-REV107C.
According to the results, neither hybrid protein acts the same as
wild type proteins, and the cell death modulation functions of
NTD for TIG3 and H-REV107 are speciﬁc toward their own CTDs.
3.2. Solution structure of TIG3N
We next solved the solution structure of TIG3N to see whether
the functional differences for TIG3N and H-REV107N are related to
their structures. The solution structure of TIG3N was calculated
using 3510 distance restraints and 125 dihedral angle restraints.
Twenty of the lowest AMBER energy conformers were selected to
represent the structure of TIG3N. The constraints and structural
statistics are summarized in Table 1.
The structure of TIG3N comprises a six-b-stranded anti-parallel
b-sheet (b1, residues 13–17; b2, residues 23–29; b3, residues
32–37; b4, residues 58–64; b5, residues 73–76; b6, residues
103–104) and four a-helices (a1, residues 65–69; a20,
residues 79–82; a2, residues 89–99; a3, residues 112–122)
(Figs. 1A and 3A). In addition to the ﬂexible N-terminal (residues
1–10) and C-terminal (residues 123–125) tails, TIG3N contains a
highly ﬂexible loop region (residues 38–57, designated as main
loop) connecting b3 and b4 (Figs. 3A and S2). As a result, there is
no NH signal for six residues in the 2D 1H-15N HSQC spectrum
(Fig. S1) and very few interproton NOEs in this region. Both cis-
and trans-isomers are observed for P43, which results in two sets
of NH crosspeaks for residues 41, 42, 44, 45 (Fig. S1) and structure
calculation was based on the trans-isomer.
The overall structure of TIG3N is very close to that of
H-REV107N, with backbone heavy atom RMSD for the secondary
structure regions of 0.8 Å between mean structures
(Figs. 1A and 3B), and the corresponding region of main loop in
TIG3 is also a highly ﬂexible loop in H-REV107N (residues 38–57)
[19]. The most signiﬁcant difference in structure is in residues
79–82, which form a short helix in TIG3N but are disordered in
H-REV107N. It was reported that residues H23, H35 and C113 of
Fig. 2. CTDs of TIG3 and H-REV107 induced HeLa cells death independently. (A) Comparison of cell death rates at 24 h and 48 h post-transfection. BFP was transfected as
negative control and all the other designed proteins were tagged with BFP as described before. Values are means ± S.D. (n = 3). Student’s t test: *, P < 0.05; **, P < 0.01; NS,
P > 0.05. (B) Cellular localization of NTDs and CTDs of TIG3 and H-REV107, and hybrid proteins. Micrographs depict cells expressed designed protein (blue) either stained with
MitoTracker Red (mitochondria) (red) or applied with CellLight Peroxisome-GFP (peroxisomes) (green), visualized by ﬂuorescence microscopy. The merged images are
overlays of blue and red/green channels, respectively. Arrows indicate the colocalization. Bars = 10 lm.
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the conserved corresponding residues in TIG3 are also positioned
in a similar fashion to those in H-REV107N.
3.3. Interaction between NTD and CTD in TIG3 and H-REV107
As the overall folds for NTDs of TIG3 and H-REV107 are quite
similar, we wondered whether their NTDs may interact with their
CTDs differently. We tried to express both full-length proteins and
CTDs in E. coli but failed in obtaining soluble proteins. However, we
were able to obtain soluble longer fragments containing 11 or 12
more residues from CTDs for both proteins, which consist the lin-
ker region (C-linker) between NTD and the predicted transmem-
brane helix together with residues 123–125 (Fig. 1A), namely
TIG3NL (residues 1–136) and H-REV107NL (residues 1–137)
(Fig. 1B).
By comparing 2D 1H-15N HSQC spectra of TIG3NL and H-
REV107NL with those of TIG3N and H-REV107N, respectively, it
is obvious that most of the NTD signals are not affected by theextra residues (Fig. 4A and B). Thus, the including of C-linkers
should not affect the overall folds of TIG3N and H-REV107N.
Meanwhile, some NH signals are perturbed by the extra residues,
which is an indication of direct interaction between CTD and NTD.
For TIG3, residues with Ddcomb of NH signals over 0.04 ppm are
residues 24, 79–85 (82 unassigned), 114, 115, 118, 119, 123–125
(Figs. 4A and S3 upper), Ddcomb of side-chain NH2 signals over
0.04 ppm are residues 24, 77, 85, 119, 121 (Fig. 4A). For H-
REV107, residues withDdcomb of NH signals over 0.04 ppm are resi-
dues 23, 80, 87, 95, 105, 106, 109, 112, 114–117, 119, 120, 122–125
(Figs. 4B and S3 lower), Ddcomb of side-chain NH2 signals over
0.04 ppm are residues 112 and 118 (Fig. 4B). Mapping these resi-
dues on the structures, it is clear that NH signals of residues 80,
114, 115, 118, 119, 123–125 are inﬂuenced by C-linkers in both
TIG3 and H-REV107, and they are mainly located on a3 helices.
Other residues affected in TIG3 are mainly distributed around a20
helix and the side of a3 helix facing a20 helix (Fig. 4C), while those
in H-REV107 are mainly distributed in a2 helix and the loop fol-
lowing b6 strand, along with the side of a3 helix facing a2 helix
Table 1








Dihedral angel restraints (u & w) 125
Hydrogen bond restraints 6
Structure statistics (20 structures)
Violation
Distance (>0.2 Å) 0
Dihedral angle (>5) 0
RMSD from mean structure (Å)
Backbone heavy atoms in secondary structures 0.37 ± 0.07
All heavy atoms in secondary structures 0.87 ± 0.10
Ramachandran statistics (%)
Residues in most favored regions 87.9
Residues in additional allowed regions 10.7
Residues in generously allowed regions 0.5
Residues in disallowed regions 0.9
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H-REV107NL are on opposite sides of a3 helices, indicating that
CTDs of TIG3 and H-REV107 should have different binding regions
on their corresponding NTDs, even though both NTDs have very
similar overall folds. The CTD binding region is at the area between
a3 helix and a20 helix for TIG3, while it is located at the area
deﬁned by a3 and a2 helices, along with the loop between b6
strand and a3 helix for H-REV107.
4. Discussions
In this paper we report that the C-terminal domains can induce
HeLa cell death independently for both TIG3 and H-REV107. NTD ofFig. 3. Solution structure of TIG3N (PDB: 2MY9) and the comparison with H-REV107N
structures of TIG3N (left), and the ribbon representation of the mean structure with se
structures of TIG3N (blue) and H-REV107N (pink) in ribbon diagram with a 180 rotatioTIG3 can enhance the cell death inducing ability of CTD while NTD
of H-REV107 on the contrary suppresses its CTD in inducing cell
death, even though neither NTD can induce cell death alone.
Apparently, the cell death inducing activity for both CTDs must
be independent of their phospholipase A/acyltransferase activities
as their NTDs are the catalytic domains [15–18], and the NC motifs
are not involved either.
We have solved the solution NMR structure of TIG3N, which is
quite similar with the structure of H-REV107N in overall fold, con-
sistent with their similarity in primary sequences. However, NMR
characterization of longer fragments (NTD plus C-linker) of TIG3
and H-REV107 suggests that their CTD binding regions on NTD
are different and located on opposite sides of the last a3 helices.
Comparison of electrostatic surfaces for both TIG3 and H-REV107
NTDs, and analysis of the amino acid sequences of the linker region
between NTDs and the transmembrane helices, reveal that the dif-
ference in CTD binding regions on NTDs is likely to be related to
different distribution patterns of charged residues between TIG3
and H-REV107.
The CTD binding region on TIG3 contains a negatively charged
patch due to residues E15, E83 and E114, which makes it possible
to interact with the N-terminal half of C-linker containing 3 posi-
tively charged residues (K124, R126 and K128) (Fig. 4C and E).
The C-terminal half of TIG3 C-linker is also very hydrophilic with
2 positively and 2 negatively charged residues (E131, K132,
K134, and E136). Meanwhile, the corresponding region on H-
REV107N has positively charged residues K83 and K79, with the
side-chain of residue K79 positioned at the center of this area
and forming a salt bridge with residue E114 (Fig. 4D). As a result,
the negatively charged patch of TIG3N does not exist in the
corresponding area of H-REV107N due to the two positive charges
(Fig. 4F), even though residues E15 and E114 are conserved in both
proteins. Therefore, CTD of TIG3 is unlikely able to bind this area of
H-REV107N, consistent with that HNTC hybrid protein (H-
REV107N fused to TIG3C) shows similar cell death inducing ability(PDB: 2KYT). (A) Superimposition of the backbone traces of the 20 representative
condary structural elements labeled (right). (B) Structural comparison of the mean
n.
Fig. 4. Characterization the CTD binding regions on NTD in TIG3NL and H-REV107NL. (A) and (B) Overlay of 2D 1H-15N HSQC spectra of TIG3N (red) with TIG3NL (blue),
H-REV107N (red) and H-REV107NL (blue). Residues whose chemical shift changes above 0.04 ppm are indicated. (C) and (D) The inﬂuenced regions on TIG3N or H-REV107N
by C-linkers in TIG3NL or H-REV107NE. Residues with combined NH chemical shift changes of 0.04–0.08 ppm are colored pink, above 0.08 ppm are magenta. CTD binding
regions are indicated with gray ellipses. Side-chain of acidic residues are colored in red, basic residues in blue, hydrophobic residues in yellow, S79 of TIG3 in green. (E) and (F)
Electrostatic potential distribution on solvent-accessible surfaces of TIG3N and H-REV107N. The ﬂexible C-terminal residues 123–125 are not included. Negative charged,
neutral and positive charged are colored red, white and blue. Electrostatic surface potential was calculated using MOLMOL [48]. Amino acid sequences of C-linkers of TIG3 and
H-REV107 are also shown.
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same as free TIG3C.
We also mutated S79 of TIG3 into lysine, which should intro-
duce a positive charge in the center of the negatively charged patch
of the CTD binding region, as it does in H-REV107N. We analyzed
the cell death inducing activity of BFP fused TIG3S79K mutant(BFP-TIG3S79K) (Fig. 1B), and the results showed that 19% and
41% of HeLa cells died at 24 h and 48 h post transfection, signiﬁ-
cantly lower than those of the full-length TIG3 (Fig. 2A). The cell
death rates of TIG3S79K mutant were also similar to those of
TIG3C, indicating that S79K mutation abolishes the cell death
enhancing ability of TIG3 NTD, presumably due to that its
H. Wei et al. / FEBS Letters 589 (2015) 1179–1186 1185interaction with CTD is impaired by the mutation. NMR character-
izations of TIG3NS79K (Fig. 1B) shows that this mutation does not
affect the overall fold (Fig. S5).
The CTD binding region on H-REV107N is mainly consisted of
hydrophobic residues (V104, L105, Y106, and F116) with a pair of
salt bridge (R95 and E119) close to the C-terminus (Fig. 4D and F).
C-linker of H-REV107 has 2 positively (R126 and R131) and 2 nega-
tively (D128 and D132) charged residues, which may interact with
the salt-bridge. In addition, the last 5 residues of C-linker are all
hydrophobic, which could possibly interact with the hydrophobic
area of the CTD binding region on H-REV107N. On the other hand,
as the corresponding region on TIG3N is fully hydrophobic
(Fig. 4E), it is possible that this region could interact with the trans-
membrane helix and the hydrophobic residues in C-linker of H-
REV107C in the hybrid protein TNHC (TIG3N fused to H-
REV107C), and thus impairs the functions of H-REV107 CTD, which
may explain why the hybrid protein TNHC is diffused in cytosol and
can no longer induce cell death.
As the CTD binding region on H-REV107N is close to its ﬂexible
main loop, whereas the CTD binding region on TIG3N is away from
the main loop, we suspected that the transmembrane helix of H-
REV107 might interact with the main loop. To test this, we
expressed BFP fused main loop deletion mutants of TIG3 (BFP-
TIG3-Dloop, residues 42–53 removed) and H-REV107 (BFP-H-
REV107-Dloop, residues 44–53 removed) in HeLa cells (Fig. 1B),
and assayed their cell death inducing abilities. The cell death rates
at 24 h and 48 h post-transfection of TIG3-Dloop were 34% and
65%, similar to those of wild type TIG3 (Fig. 2A). It indicates that
the removal of the main loop has no effect on TIG3’s function, sug-
gesting that the main loop does not interfere with CTD in TIG3,
consistent with our hypothesis. Interestingly, cell death inducing
ability was enhanced for H-REV107 with the removal of the main
loop, and the cell death rates of H-REV107-Dloop were 18% and
33% at 24 h and 48 h post-transfection, comparable to the levels
of H-REV107C alone (Fig. 2A). Therefore, the suppression of CTD
cell death inducing activity of H-REV107 by its NTD is very likely
due to the binding of the CTD by the main loop, and thus the
removal of the main loop abolishes the inhibition. NMR character-
izations indicated that the removal of the main loop should not
affect the overall fold for either TIG3N or H-REV107N (Figs. 1B
and S4).
It was reported that the N-terminal domain residues 102–125
motif is required for the pericentrosomal localization of full-length
TIG3 [28]. While as the corresponding motif in H-REV107 may be
fully covered by its CTD from our structural data, the residues
102–125 motif in TIG3 should be mainly exposed even though
the interaction between CTD and NTD in TIG3 partially involves
a3 helix, which makes it possible to contribute to the subcellular
localization.
It is still not clear how the CTDs of TIG3 and H-REV107 induce
tumor cell death, and also whether their phospholipase A/acyl-
transferase enzyme activities play roles in cell death. More future
studies are needed to reveal the function mechanisms for the H-
REV107 family proteins.
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